City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic atrophy (GA). The early-stage deal breaks down like this: City gets an ...

Pre-tax losses at the main Irish unit of eye care product firm Bausch + Lomb increased by 4.5% to $959.7m (€925m) in 2023. Accounts recently filed by Bausch + Lomb Ireland Ltd show that pre-tax ...

Niklas Beste was the driving force behind the attacking exploits of Bundesliga surprise package Heidenheim in 2023/24, and is now back in the Bundesliga with Freiburg. bundesliga.com looks into ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Niklas Zennström, one of Europe’s most successful tech entrepreneurs and investors, believes the ...

Bausch + Lomb acquired Whitecap Biosciences to develop therapies for glaucoma and geographic atrophy, aiming to improve visual outcomes. Whitecap's WB007, an alpha-2 adrenergic agonist, showed IOP ...

Jersey City-based Character Biosciences, a company specializing in genetics-guided drug discovery and development, has announced a collaboration with Bausch + Lomb, a leading global eye health company ...

City Therapeutics, Inc. set to collaborate with Bausch + Lomb on the development of a novel therapy for the treatment of retinal diseases including geographic atrophy (GA). The arrangement of this ...

Atlético Madrid signed an important comeback victory against a Leverkusen team that started winning with a goal by Piero ...

Bodoland FC vs Odisha FC Live Score, Durand Cup 2024: Odisha ...